Preliminary investigation of the radiosensitizing activity of guduchi (tinospora cordifolia) in tumor-bearing mice

Phytotherapy Research

Volumn 22, Issue 11, 2008, Pages 1482-1489

  Rao, Shaival Kamalaksha ^a   Rao, Priya Shaival ^a   Rao, B Nageshwara ^b  

^a C U SHAH UNIVERSITY   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Ehrlich ascites carcinoma; Glutathione; Glutathione S transferase; Guduchi; Lipid peroxidation; Radiosensitization

Indexed keywords

DICHLOROMETHANE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; RADIOSENSITIZING AGENT; TINOSPORA CORDIFOLIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEPLETION; DNA DAMAGE; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG ISOLATION; DRUG MECHANISM; EHRLICH ASCITES TUMOR; FEMALE; GAMMA IRRADIATION; LIPID PEROXIDATION; MOUSE; NONHUMAN; RADIATION DOSE; RADIOSENSITIZATION; SURVIVAL TIME; TINOSPORA; TUMOR MODEL;

ANIMALS; CARCINOMA, EHRLICH TUMOR; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA RAYS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDATION; MICE; NEOPLASM TRANSPLANTATION; PHYTOTHERAPY; PLANT EXTRACTS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TINOSPORA;

ANIMALIA; MENISPERMACEAE; MUS; TINOSPORA CORDIFOLIA;

EID: 57349142518     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2508     Document Type: Article

References (40)

1. Abramowitz M, Stegun IA. 1972. Handbook of Mathematical Functions. Dover Publications, Inc: New York.
2. Beuege JA, Aust SD. 1978. Microsomal lipid peroxidation. Method Enzymol 30: 302-310.
3. Bridges BA, Ashwood-Smith MJ, Munson RJ. 1969. Susceptibility of mild thermal and of ionizing radiation damage to the same recovery mechanisms in Escherichia coli. Biochem Biophys Res Commun 29: 193-196.
4. Brown JM. 1977. Cytotoxic effects of the hypoxic cell radio-sensitizer RO-07-0582 to tumor cells in vivo. Radiat Res 72: 469-486.
5. Cachin Y, Jortay A, Sancho H, Eschwege F, Madelain M. 1977. Preliminary results of a randomized E.O.R.T.C. study comparing radiotherapy and concomitant bleomycin to radio-therapy alone in epidermoid carcinomas of the oropharynx. Eur J Cancer 13: 1389-95.
6. Carde P, Laval F. 1995. Effect of cis-dichlorodiammine platinum II and X-rays on mammalian cell survival. Int J Radiat Oncol Biol Phys 17: 929-933.
7. Coleman CN, Mitchell JB. 1999. Clinical radiosensitization: why it does and does not work. J Clin Oncol 17: 1-3.
8. Comparti M, Macllaro E, DelBello B, Casini AF. 1991. Gutathione depletion, its effects on other oxidant systems and hepatocellular damage. Xenobiotica 21: 1067-1076.
9. Cragg GM, Newman DJ, Snader KM. 1997. Natural products in drug discovery and development. J. Nat. Prod 60: 52-60.
10. Creane M, Seymour CB, Colucci S, Mothersill C. 1999. Radio-biological effects of docetaxel (Taxotere): a potential radiation sensitizer. Int J Radiat Biol 75: 731-737.
11. Crissman JD, Pajak TF, Zarbo RJ, Marcial VA, Al-Sarraf M. 1987. Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck - an RTOG study of 114 advanced stage tumors. Cancer 59: 1391-1397.
12. Dunton CJ, King SA, Neufeld J, Tolosa J, Perez G, Avila A, Underhill K. 2002. Phase I study of topotecan and radiation therapy in advanced cervical cancer. Gynecol Oncol 85: 185-187.
13. Geran Rl, Greenberg NH, Mac Donald MM, Schumacher AM, Abbott BJ. 1972. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemotherapy Reports Part 3.2(3): 25-27.
14. Giocanti N, Hennequin C, Balosso J, Mahler M, Favaudon V. 1993. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53: 2105-2111.
15. Gupta NK, Pointon RC, Wilkinson PM. 1987. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 38: 575-581.
16. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
17. Jagetia GC, Nayak V, Vidyasagar MS. 1998. Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells. Cancer Lett 127: 71-82.
18. Jagetia GC, Nayak V, Vidyasagar MS. 2002. Enhancement of radiation effect by Guduchi (Tinospora cordifolia) in HeLa cells. Pharm Biol 40: 179-188.
19. Jagetia GC, Rao Shaival K. 2006a. Evaluation of the antineoplastic activity of Guduchi (Tinospora cordifolia) in Ehrlich Ascites Carcinoma bearing mice. Biol Pharm Bull 29: 460-466.
20. Jagetia GC, Rao Shaival K. 2006b. Evaluation of cytotoxic effects of dichloromethane extract of guduchi (Tinospora cordifolia Miers Ex Hook F & Thorns) in cultured HeLa cells. Evid Based Comp & Alt Med 3: 267-272.
21. Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD. 1995. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res 15: 2643-2649.
22. Marcial VA, Pajak TF, Mohiuddin M, Cooper J, al Saraff M. 1990. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck-Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer 66: 1861-1868.
23. Masunaga SI, Ono K, Suzuki M, Kinashi Y, Hori H. 2001. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Int J Radiat Oncol Biol Phys 50: 1063-1072.
24. Matsuura M, Hasegawa M, Hayakawa K, Kawashima M, Nasu S, Nakamura Y, Mitsuhashi N, Niibe H. 2000. Experimental study of the effects on apoptosis of docetaxel alone and in combination with irradiation. Oncol Rep 7: 289-293.
25. Matsuzawa T, Onozawa M, Morita K, Kakehi M. 1972. Radiosensitization of bleomycin on lethal effect of mouse cancer cell in vitro. Strahlentherapie 144: 614-617.
26. McGinn CJ, Lawrence TS, Zalupski MM. 2002. On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer. Cancer 95: 933-940.
27. Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver, Biochim Biophys Acta 582: 67-78.
28. Murata R, Overgaard J, Horsman MR. 2001. Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy. Int J Radiat Oncol Biol Phys 51: 1018-1024.
29. Nias AHW. 1990. Radiation Biology. In Treatment of cancer. Sikora K, Halnan KE (eds). Chapman and Hall Medical: London; 53-75.
30. Owen DG, McNamee JP, Raaphorst GP, Ng CE. 2002. Potentiation of cell killing by low-dose-rate radiation by camptothecin is related to an increase in the level of DNA double-strand breaks. Radiat Res 157: 149-157.
31. Ozols RF, Hamilton TC, Young RC. 1988. Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer. Prog Clin Biol Res 276: 287-293.
32. Pachaly P, Schneider C. 1981. Alkaloids from Tinospora cordifolia Miers. Arch Pharmacol 314: 251-256.
33. Padhya MA. 1986. Biosynthesis of isoquinoline alkaloid berberine in tissue cultures of Tinospora cordifolia. Indian Drugs 24: 47-48.
34. Qudrat-l-Khuda M, Khaleque A, Ray N. 1964. Tinospora cordifolia. L. Constituents of the plant fresh from the field. Scientific Research (Dacca) 1: 177-183.
35. Sarma DNK, Padma P, Khosa RL. 1998. Constituents of Tinospora cordifolia root. Fitoterapia 69: 541-542.
36. Tannock IF. 1996. Treatment of cancer with radiation and drugs. J Clin Oncol 14: 3156-3174.
37. Teicher BA, Forler P, Menon K, Phares V, Amsrud T, Shih C. 2000. Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenografts. In Vivo 14: 471-480.
38. Tishler RB, PB Schiff, CR Geard, Hall EJ. 1992. Taxol: A novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22: 613-617.
39. Turner A, Pearcey RG. 1996. Effect of cisplatin on the clinically relevant radiosensitivity of human carcinoma cell lines. Int J Radiat Oncol Biol Phys 34: 367-374.
40. Vickers A. 2002. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest 20: 1069-1079.